Recent Finacing
Recent Raise
Alessa Therapeutics develops proprietary localized, sustained‑release drug‑eluting implants, including Enolen (enzalutamide‑eluting seed) designed to deliver antiandrogen therapy selectively to the prostate for localized prostate cancer.
